UniProt ID | SPHK2_HUMAN | |
---|---|---|
UniProt AC | Q9NRA0 | |
Protein Name | Sphingosine kinase 2 | |
Gene Name | SPHK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 654 | |
Subcellular Localization |
Isoform 1: Cytoplasm. Membrane. Isoform 2: Lysosome membrane. |
|
Protein Description | Catalyzes the phosphorylation of sphingosine to form sphingosine 1-phosphate (SPP), a lipid mediator with both intra- and extracellular functions. Also acts on D-erythro-dihydrosphingosine, D-erythro-sphingosine and L-threo-dihydrosphingosine. Binds phosphoinositides.. | |
Protein Sequence | MNGHLEAEEQQDQRPDQELTGSWGHGPRSTLVRAKAMAPPPPPLAASTPLLHGEFGSYPARGPRFALTLTSQALHIQRLRPKPEARPRGGLVPLAEVSGCCTLRSRSPSDSAAYFCIYTYPRGRRGARRRATRTFRADGAATYEENRAEAQRWATALTCLLRGLPLPGDGEITPDLLPRPPRLLLLVNPFGGRGLAWQWCKNHVLPMISEAGLSFNLIQTERQNHARELVQGLSLSEWDGIVTVSGDGLLHEVLNGLLDRPDWEEAVKMPVGILPCGSGNALAGAVNQHGGFEPALGLDLLLNCSLLLCRGGGHPLDLLSVTLASGSRCFSFLSVAWGFVSDVDIQSERFRALGSARFTLGTVLGLATLHTYRGRLSYLPATVEPASPTPAHSLPRAKSELTLTPDPAPPMAHSPLHRSVSDLPLPLPQPALASPGSPEPLPILSLNGGGPELAGDWGGAGDAPLSPDPLLSSPPGSPKAALHSPVSEGAPVIPPSSGLPLPTPDARVGASTCGPPDHLLPPLGTPLPPDWVTLEGDFVLMLAISPSHLGADLVAAPHARFDDGLVHLCWVRSGISRAALLRLFLAMERGSHFSLGCPQLGYAAARAFRLEPLTPRGVLTVDGEQVEYGPLQAQMHPGIGTLLTGPPGCPGREP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
105 | Phosphorylation | SGCCTLRSRSPSDSA ECCEEECCCCCCCCC | 39.98 | 19276368 | |
107 | Phosphorylation | CCTLRSRSPSDSAAY CEEECCCCCCCCCEE | 29.96 | 19276368 | |
109 | Phosphorylation | TLRSRSPSDSAAYFC EECCCCCCCCCEEEE | 45.50 | 28464451 | |
111 | Phosphorylation | RSRSPSDSAAYFCIY CCCCCCCCCEEEEEE | 21.09 | 28464451 | |
114 | Phosphorylation | SPSDSAAYFCIYTYP CCCCCCEEEEEEECC | 9.94 | 28450419 | |
262 (in isoform 3) | Phosphorylation | - | 67.33 | 22210691 | |
263 (in isoform 3) | Phosphorylation | - | 14.17 | 25627689 | |
264 (in isoform 3) | Phosphorylation | - | 43.38 | 25627689 | |
265 (in isoform 3) | Phosphorylation | - | 55.28 | 25627689 | |
266 (in isoform 3) | Phosphorylation | - | 8.50 | 22210691 | |
267 (in isoform 3) | Phosphorylation | - | 6.54 | 22210691 | |
273 (in isoform 3) | Phosphorylation | - | 3.85 | 25627689 | |
274 (in isoform 3) | Phosphorylation | - | 2.06 | 25627689 | |
355 | Phosphorylation | ERFRALGSARFTLGT HHHHHHHCHHHHHHH | 19.68 | 24043423 | |
359 | Phosphorylation | ALGSARFTLGTVLGL HHHCHHHHHHHHHHH | 20.80 | 24043423 | |
362 | Phosphorylation | SARFTLGTVLGLATL CHHHHHHHHHHHHHH | 18.70 | 24043423 | |
363 (in isoform 3) | Phosphorylation | - | 3.66 | 25159151 | |
368 | Phosphorylation | GTVLGLATLHTYRGR HHHHHHHHHHHHCCC | 24.90 | 24043423 | |
368 (in isoform 3) | Phosphorylation | - | 24.90 | 25159151 | |
371 | Phosphorylation | LGLATLHTYRGRLSY HHHHHHHHHCCCCCC | 20.30 | 24043423 | |
372 | Phosphorylation | GLATLHTYRGRLSYL HHHHHHHHCCCCCCC | 10.58 | 24043423 | |
377 | Phosphorylation | HTYRGRLSYLPATVE HHHCCCCCCCCCCCC | 24.22 | 23403867 | |
378 | Phosphorylation | TYRGRLSYLPATVEP HHCCCCCCCCCCCCC | 22.69 | 23403867 | |
382 | Phosphorylation | RLSYLPATVEPASPT CCCCCCCCCCCCCCC | 24.38 | 30266825 | |
387 | Phosphorylation | PATVEPASPTPAHSL CCCCCCCCCCCCHHC | 39.77 | 29255136 | |
389 | Phosphorylation | TVEPASPTPAHSLPR CCCCCCCCCCHHCCC | 30.52 | 30266825 | |
393 | Phosphorylation | ASPTPAHSLPRAKSE CCCCCCHHCCCCCCC | 42.02 | 30266825 | |
399 | Phosphorylation | HSLPRAKSELTLTPD HHCCCCCCCCEECCC | 36.53 | 23401153 | |
402 | Phosphorylation | PRAKSELTLTPDPAP CCCCCCCEECCCCCC | 25.24 | 21712546 | |
404 | Phosphorylation | AKSELTLTPDPAPPM CCCCCEECCCCCCCC | 22.02 | 25159151 | |
414 | Phosphorylation | PAPPMAHSPLHRSVS CCCCCCCCCCCCCHH | 21.44 | 25159151 | |
419 | Phosphorylation | AHSPLHRSVSDLPLP CCCCCCCCHHCCCCC | 18.41 | 17635916 | |
421 | Phosphorylation | SPLHRSVSDLPLPLP CCCCCCHHCCCCCCC | 34.38 | 17635916 | |
472 | Phosphorylation | LSPDPLLSSPPGSPK CCCCCCCCCCCCCCC | 48.78 | 26074081 | |
473 | Phosphorylation | SPDPLLSSPPGSPKA CCCCCCCCCCCCCCH | 34.77 | 20363803 | |
477 | Phosphorylation | LLSSPPGSPKAALHS CCCCCCCCCCHHHCC | 29.06 | 20363803 | |
484 | Phosphorylation | SPKAALHSPVSEGAP CCCHHHCCCCCCCCC | 28.04 | 26055452 | |
487 | Phosphorylation | AALHSPVSEGAPVIP HHHCCCCCCCCCCCC | 33.43 | 26055452 | |
496 | Phosphorylation | GAPVIPPSSGLPLPT CCCCCCCCCCCCCCC | 31.51 | 26074081 | |
497 | Phosphorylation | APVIPPSSGLPLPTP CCCCCCCCCCCCCCC | 50.55 | 26074081 | |
503 | Phosphorylation | SSGLPLPTPDARVGA CCCCCCCCCCCCCCC | 41.29 | 26074081 | |
614 | Phosphorylation | AFRLEPLTPRGVLTV HHCCCCCCCCEEEEE | 22.96 | 22817900 | |
620 | Phosphorylation | LTPRGVLTVDGEQVE CCCCEEEEECCEEEE | 17.72 | 30257219 | |
641 | Phosphorylation | QMHPGIGTLLTGPPG EECCCCCCCCCCCCC | 19.37 | 30257219 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
387 | S | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
387 | S | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
387 | S | Phosphorylation | Kinase | MAPK | - | Uniprot |
419 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
419 | S | Phosphorylation | Kinase | PDPK1 | Q9Z2A0 | GPS |
419 | S | Phosphorylation | Kinase | PKD | - | Uniprot |
421 | S | Phosphorylation | Kinase | PRKD1 | Q15139 | PSP |
421 | S | Phosphorylation | Kinase | PDPK1 | Q9Z2A0 | GPS |
421 | S | Phosphorylation | Kinase | PKD | - | Uniprot |
614 | T | Phosphorylation | Kinase | MAPK1 | P28482 | GPS |
614 | T | Phosphorylation | Kinase | MAPK3 | P27361 | GPS |
614 | T | Phosphorylation | Kinase | MAPK | - | Uniprot |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SPHK2_HUMAN !! |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle."; Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.; Mol. Cell 31:438-448(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-387; THR-404 ANDSER-414, AND MASS SPECTROMETRY. |